Einstein Experts for Media
Diabetes
Meredith A. Hawkins, M.D., M.S.
Professor, Medicine (Endocrinology), Einstein
Director, Global Diabetes Institute, Einstein
Attending Physician, Medicine, Montefiore Health System
Harold and Muriel Block Chair in Medicine, Einstein
DiabetesGlobal diabetesType 2 diabetes
Malnutrition diabetesGlobal health
Dr. Hawkins specializes in diabetes, with a particular emphasis on the dramatic rise of the disease worldwide. She has traveled the globe investigating diabetes since 1996 and is the founding director of the Global Diabetes Institute (GDI) at Einstein, which conducts diabetes education and training for healthcare workers in South and Central America, Eastern Europe, Africa and Asia. read more...
Judith Wylie-Rosett, Ed.D.
Professor, Epidemiology & Population Health (Health Promotion and Nutrition Research)
Professor, Medicine (Endocrinology)
Division Head, Health Promotion and Nutritional Research, Department of Epidemiology & Population Health
Atran Foundation Chair in Social Medicine
NutritionObesityWeight management
Behavior modificationType 2 diabetes
Dr. Wylie-Rosett’s research focuses on nutrition’s role in preventing and controlling chronic diseases—particularly diseases such as type 2 diabetes and heart disease in which obesity is an important risk factor. She is associate editor of the journal Diabetes Care and author of The Complete Weight Loss Workbook. Dr. Wylie-Rosett has helped the American Diabetes Association and American Heart Association develop nutrition-related recommendations and position statements. read more...
Jill P. Crandall, M.D.
Professor, Department of Medicine (Endocrinology)
Jacob A. and Jeanne E. Barkey Chair in Medicine
Chief, Division of Endocrinology
Director, Fleischer Institute for Diabetes and Metabolism
DiabetesType 2 diabetesDiabetes prevention
Clinical TrialsPrediabetesResveratrol
An expert in diabetes prevention, Dr. Crandall is director of the Diabetes Clinical Trials Unit at Einstein and Montefiore and a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE) and the PERL (Preventing Early Renal Loss) study. read more...
Jeffrey E. Pessin, Ph.D.
Professor, Medicine (Endocrinology)
Professor, Molecular Pharmacology
Director, Einstein-Mount Sinai Diabetes Research Center
Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research
DiabetesType 1 diabetesMetabolism
Dr. Pessin directs the Einstein-Mount Sinai Diabetes Research Center, one of only sixteen NIH-funded diabetes centers of its kind in the country. He guides the research of more than 90 scientists investigating type 1 (formerly juvenile) and type 2 (formerly adult-onset) diabetes. The center also includes training programs and community-based activities in the Bronx. Dr. Pessin’s own research focuses on insulin signaling and the mechanisms contributing to the onset of type 1 diabetes. read more...
Elizabeth A. Walker, Ph.D.
Professor, Medicine (Endocrinology)
Professor, Epidemiology & Population Health
Associate Director, Einstein-Mount Sinai Diabetes Research Center
Director of the Einstein Diabetes Prevention & Control Core
Diabetes Self-Management (behavior change)Type 2 diabetesBehavioral interventionPublic health
Dr. Walker is a nurse scientist, diabetes nurse specialist and certified diabetes educator who specializes in studying how to help people with diabetes better manage their disease by adhering to their medication regimen, eating a healthy diet, exercising, and getting regular screening for complications. She is recognized for leading large NIH-funded behavioral intervention studies in minority diabetes populations—and has a program of research studies showing that regular phone calls to people with diabetes can be successful in helping them self-manage their disease and improve their diabetes control. read more...